To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Intravenous Unit-Dose Tranexamic Acid for Blood Loss Management in Posterior Lumbar Interbody Fusion

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
May 2023

Intravenous Unit-Dose Tranexamic Acid for Blood Loss Management in Posterior Lumbar Interbody Fusion

Vol: 303| Issue: 5| Number:23| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

The effect of intravenous unit-dose tranexamic acid on visible and hidden blood loss in posterior lumbar interbody fusion: a randomized clinical trial.

Sci Rep. 2023 Mar 22;13(1): 4714.

Contributing Authors:
S Hao H Li S Liu S Meng X Zhang L Wang H Yang L Zhang S Dong

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

100 patients undergoing a posterior lumbar interbody fusion procedure were randomized to receive a unit dose of intravenous tranexamic acid 15 minutes before skin incision (n=50) or normal saline (n=50). The outcomes of interest included operative time, blood loss, drainage volume, transfusion rate, events, coagulation and inflammatory markers. Biomarkers were measured at 1 and 4 days post-operati...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.